An Approved Vendor for
Over 11 Years

>300 Studies Supported

>100 Scientists
Supported

BI has dedicated support from Discovery’s Strategic Account Management focused on orchestrating true enterprise-wide partnership. Our aim is to streamline communications, strengthen relationships, facilitate agreements, broaden support, and expedite solutions to advance BI projects. 

Over the years, Discovery has delivered creative solutions across multiple BI research groups. Examples of these tailored solutions include custom biospecimen bank builds, high-throughput RNA, whole genome, exome, targeted sequencing, and customizable multiplex immunoassays. 

Discovery provided a multitude of tissues to support assay development for many markers. This included prevalence studies for strategic projects where assays were implemented into clinical trials. 

Large strategic bank build of Discovery FFPE to support oncology projects. Discovery is committed to helping BI single-source more large cohorts to streamline processes. 

• Largest selection available spanning most solid tumor indications
• World-class scientific support for DTCs utilization
• Flow and genomic characterizations available for optimal sample selections

• Pathologist reviewed, fully consented FFPE blocks and matched sets. 

• 40x Digital H&E images of all blocks for easy review and selection  

• Wide range of expert tissue biomarker and genomic services available for further characterization  

• GMP and RUO Leukopaks
• 99% delivery rate
• Tens of thousands of highly characterized donors available
• World's largest apheresis capacity to deliver RUO and GMP-compliant products

Reliable and customizable proteomic services from multiplexed immunoassay such as Olink to mass spectrometry enabling improved understanding of real-time human biology.

High-throughput RNA-Seq, WES, targeted and pan-caner sequencing workflows optimized in GCLP-compliant service laboratories for the most challenging sample types such as FFPE and core needle biopsies.  

Pathologist-driven, GCLP-compliant procedure for developing and validating AI driven digital image analysis and custom IHC/mIF assays in CAP-accredited and CLIA-certified and IVDR ready laboratories.